Fiera Capital (Canada)’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.24M Buy
24,146
+5,289
+28% +$1.41M 0.02% 236
2025
Q4
$4.65M Buy
18,857
+3,794
+25% +$799K 0.01% 238
2025
Q3
$2.66M Sell
15,063
-448
-3% -$67.1K 0.01% 273
2025
Q2
$2.13M Sell
15,511
-134
-0.9% -$19.7K 0.01% 292
2025
Q1
$2.82M Sell
15,645
-28
-0.2% -$4.71K 0.01% 276
2024
Q4
$2.46M Sell
15,673
-527
-3% -$93.5K 0.01% 278
2024
Q3
$2.95M Sell
16,200
-8
-0% -$1.54K 0.01% 266
2024
Q2
$2.98M Buy
16,208
+130
+0.8% +$21.8K 0.01% 263
2024
Q1
$2.86M Buy
16,078
+178
+1% +$24.7K 0.01% 259
2023
Q4
$1.97M Buy
+15,900
New +$1.76M 0.01% 289

Other funds holding KRYS